ID   NEK6_HUMAN              Reviewed;         313 AA.
AC   Q9HC98; B7Z2D9; Q5TBG3; Q5TBG9; Q6FG86; Q6IAR3; Q96E83; Q9ULX2;
DT   03-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   03-OCT-2003, sequence version 2.
DT   15-MAR-2017, entry version 154.
DE   RecName: Full=Serine/threonine-protein kinase Nek6;
DE            EC=2.7.11.1;
DE   AltName: Full=Never in mitosis A-related kinase 6;
DE            Short=NimA-related protein kinase 6;
DE   AltName: Full=Protein kinase SID6-1512;
GN   Name=NEK6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=12054534; DOI=10.1016/S0006-291X(02)00297-8;
RA   Hashimoto Y., Akita H., Hibino M., Kohri K., Nakanishi M.;
RT   "Identification and characterization of Nek6 protein kinase, a
RT   potential human homolog of NIMA histone H3 kinase.";
RL   Biochem. Biophys. Res. Commun. 293:753-758(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RA   Saito T., Saito R., Saito S.;
RT   "A protein kinase weakly similar to nek1.";
RL   Submitted (APR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4).
RC   TISSUE=Brain, and Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Kidney, and Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 8-313 (ISOFORMS 1/2/3/4).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   PHOSPHORYLATION AT SER-37; THR-202 AND SER-206.
RX   PubMed=12840024; DOI=10.1074/jbc.M303663200;
RA   Belham C., Roig J., Caldwell J.A., Aoyama Y., Kemp B.E., Comb M.,
RA   Avruch J.;
RT   "A mitotic cascade of NIMA family kinases. Nercc1/Nek9 activates the
RT   Nek6 and Nek7 kinases.";
RL   J. Biol. Chem. 278:34897-34909(2003).
RN   [9]
RP   FUNCTION, AUTOPHOSPHORYLATION, MUTAGENESIS OF LYS-74 AND LYS-75, AND
RP   INDUCTION.
RX   PubMed=14563848; DOI=10.1074/jbc.M308080200;
RA   Yin M.J., Shao L., Voehringer D., Smeal T., Jallal B.;
RT   "The serine/threonine kinase Nek6 is required for cell cycle
RT   progression through mitosis.";
RL   J. Biol. Chem. 278:52454-52460(2003).
RN   [10]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH PIN1.
RX   PubMed=16476580; DOI=10.1016/j.bbrc.2005.12.228;
RA   Chen J., Li L., Zhang Y., Yang H., Wei Y., Zhang L., Liu X., Yu L.;
RT   "Interaction of Pin1 with Nek6 and characterization of their
RT   expression correlation in Chinese hepatocellular carcinoma patients.";
RL   Biochem. Biophys. Res. Commun. 341:1059-1065(2006).
RN   [11]
RP   SUBCELLULAR LOCATION, INTERACTION WITH APBB1, AND PHOSPHORYLATION AT
RP   THR-210.
RX   PubMed=17512906; DOI=10.1016/j.bbrc.2007.04.203;
RA   Lee E.J., Hyun S.H., Chun J., Kang S.S.;
RT   "Human NIMA-related kinase 6 is one of the Fe65 WW domain binding
RT   proteins.";
RL   Biochem. Biophys. Res. Commun. 358:783-788(2007).
RN   [12]
RP   FUNCTION, AND PHOSPHORYLATION.
RX   PubMed=18728393; DOI=10.4161/cc.7.17.6551;
RA   Lee M.Y., Kim H.J., Kim M.A., Jee H.J., Kim A.J., Bae Y.S., Park J.I.,
RA   Chung J.H., Yun J.;
RT   "Nek6 is involved in G2/M phase cell cycle arrest through DNA damage-
RT   induced phosphorylation.";
RL   Cell Cycle 7:2705-2709(2008).
RN   [13]
RP   FUNCTION, CATALYTIC ACTIVITY, INTERACTION WITH KIF11 AND NEK9, AND
RP   MUTAGENESIS OF LYS-74 AND LYS-75.
RX   PubMed=19001501; DOI=10.1242/jcs.035360;
RA   Rapley J., Nicolas M., Groen A., Regue L., Bertran M.T., Caelles C.,
RA   Avruch J., Roig J.;
RT   "The NIMA-family kinase Nek6 phosphorylates the kinesin Eg5 at a novel
RT   site necessary for mitotic spindle formation.";
RL   J. Cell Sci. 121:3912-3921(2008).
RN   [14]
RP   DOMAIN, ENZYME REGULATION, AND MUTAGENESIS OF TYR-108.
RX   PubMed=19941817; DOI=10.1016/j.molcel.2009.09.038;
RA   Richards M.W., O'Regan L., Mas-Droux C., Blot J.M., Cheung J.,
RA   Hoelder S., Fry A.M., Bayliss R.;
RT   "An autoinhibitory tyrosine motif in the cell-cycle-regulated Nek7
RT   kinase is released through binding of Nek9.";
RL   Mol. Cell 36:560-570(2009).
RN   [15]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH NEK9.
RX   PubMed=19414596; DOI=10.1128/MCB.01867-08;
RA   O'Regan L., Fry A.M.;
RT   "The Nek6 and Nek7 protein kinases are required for robust mitotic
RT   spindle formation and cytokinesis.";
RL   Mol. Cell. Biol. 29:3975-3990(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-206, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [17]
RP   FUNCTION, AND INDUCTION.
RX   PubMed=21099361; DOI=10.4161/cc.9.23.14059;
RA   Jee H.J., Kim A.J., Song N., Kim H.J., Kim M., Koh H., Yun J.;
RT   "Nek6 overexpression antagonizes p53-induced senescence in human
RT   cancer cells.";
RL   Cell Cycle 9:4703-4710(2010).
RN   [18]
RP   FUNCTION, INTERACTION WITH ANKRA2; ATF4; ARHGAP33; CDC42; CIR1; NEK9;
RP   PRAM1; PTN; PRDX3; RAD26L; RBBP6; RPS7 AND TRIP4, PHOSPHORYLATION AT
RP   SER-206, AND AUTOPHOSPHORYLATION.
RX   PubMed=20873783; DOI=10.1021/pr100562w;
RA   Vaz Meirelles G., Ferreira Lanza D.C., da Silva J.C.,
RA   Santana Bernachi J., Paes Leme A.F., Kobarg J.;
RT   "Characterization of hNek6 interactome reveals an important role for
RT   its short N-terminal domain and colocalization with proteins at the
RT   centrosome.";
RL   J. Proteome Res. 9:6298-6316(2010).
RN   [19]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=20407017; DOI=10.1158/1541-7786.MCR-09-0291;
RA   Nassirpour R., Shao L., Flanagan P., Abrams T., Jallal B., Smeal T.,
RA   Yin M.J.;
RT   "Nek6 mediates human cancer cell transformation and is a potential
RT   cancer therapeutic target.";
RL   Mol. Cancer Res. 8:717-728(2010).
RN   [20]
RP   REVIEW.
RX   PubMed=16280549; DOI=10.1242/jcs.02681;
RA   Quarmby L.M., Mahjoub M.R.;
RT   "Caught Nek-ing: cilia and centrioles.";
RL   J. Cell Sci. 118:5161-5169(2005).
RN   [21]
RP   REVIEW.
RX   PubMed=21200151;
RA   Fry A.M.;
RT   "A role for Nek6 kinase activity in preventing senescence?";
RL   Cell Cycle 10:19-20(2011).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-206, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Protein kinase which plays an important role in mitotic
CC       cell cycle progression. Required for chromosome segregation at
CC       metaphase-anaphase transition, robust mitotic spindle formation
CC       and cytokinesis. Phosphorylates ATF4, CIR1, PTN, RAD26L, RBBP6,
CC       RPS7, RPS6KB1, TRIP4, STAT3 and histones H1 and H3. Phosphorylates
CC       KIF11 to promote mitotic spindle formation. Involved in G2/M phase
CC       cell cycle arrest induced by DNA damage. Inhibition of activity
CC       results in apoptosis. May contribute to tumorigenesis by
CC       suppressing p53/TP53-induced cancer cell senescence.
CC       {ECO:0000269|PubMed:12054534, ECO:0000269|PubMed:14563848,
CC       ECO:0000269|PubMed:18728393, ECO:0000269|PubMed:19001501,
CC       ECO:0000269|PubMed:19414596, ECO:0000269|PubMed:20407017,
CC       ECO:0000269|PubMed:20873783, ECO:0000269|PubMed:21099361}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000269|PubMed:19001501}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- ENZYME REGULATION: Binding to NEK9 stimulates its activity by
CC       releasing the autoinhibitory function of Tyr-108.
CC       {ECO:0000269|PubMed:19941817}.
CC   -!- SUBUNIT: Interacts with STAT3 and RPS6KB1 (By similarity).
CC       Interacts with NEK9, predominantly in mitosis. Interacts with
CC       KIF11 (via C-terminus). Interacts with APBB1 (via WW domain).
CC       Interacts with ANKRA2, ATF4, ARHGAP33, CDC42, CIR1, PRAM1, PTN,
CC       PRDX3, PIN1, RAD26L, RBBP6, RPS7 and TRIP4. {ECO:0000250,
CC       ECO:0000269|PubMed:16476580, ECO:0000269|PubMed:17512906,
CC       ECO:0000269|PubMed:19001501, ECO:0000269|PubMed:19414596,
CC       ECO:0000269|PubMed:20873783}.
CC   -!- INTERACTION:
CC       Q08117:AES; NbExp=3; IntAct=EBI-740364, EBI-717810;
CC       Q8IYA8:CCDC36; NbExp=3; IntAct=EBI-740364, EBI-8638439;
CC       Q5VWN6-2:FAM208B; NbExp=3; IntAct=EBI-740364, EBI-10172380;
CC       Q9BPX1:HSD17B14; NbExp=3; IntAct=EBI-740364, EBI-742664;
CC       Q13422:IKZF1; NbExp=3; IntAct=EBI-740364, EBI-745305;
CC       Q9UKT9:IKZF3; NbExp=3; IntAct=EBI-740364, EBI-747204;
CC       Q0VD86:INCA1; NbExp=3; IntAct=EBI-740364, EBI-6509505;
CC       Q15323:KRT31; NbExp=3; IntAct=EBI-740364, EBI-948001;
CC       Q6A162:KRT40; NbExp=3; IntAct=EBI-740364, EBI-10171697;
CC       Q8TBB1:LNX1; NbExp=3; IntAct=EBI-740364, EBI-739832;
CC       Q9BRK4:LZTS2; NbExp=3; IntAct=EBI-740364, EBI-741037;
CC       H3BTW2:NECAB2; NbExp=3; IntAct=EBI-740364, EBI-10172876;
CC       Q13526:PIN1; NbExp=3; IntAct=EBI-740364, EBI-714158;
CC       P15884:TCF4; NbExp=3; IntAct=EBI-740364, EBI-533224;
CC       Q07912:TNK2; NbExp=3; IntAct=EBI-740364, EBI-603457;
CC       P36406:TRIM23; NbExp=3; IntAct=EBI-740364, EBI-740098;
CC       P14373:TRIM27; NbExp=3; IntAct=EBI-740364, EBI-719493;
CC       P98170:XIAP; NbExp=3; IntAct=EBI-740364, EBI-517127;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Nucleus speckle.
CC       Cytoplasm, cytoskeleton, microtubule organizing center,
CC       centrosome. Cytoplasm, cytoskeleton, spindle pole.
CC       Note=Colocalizes with APBB1 at the nuclear speckles. Colocalizes
CC       with PIN1 in the nucleus. Colocalizes with ATF4, CIR1, ARHGAP33,
CC       ANKRA2, CDC42, NEK9, RAD26L, RBBP6, RPS7, TRIP4, RELB and PHF1 in
CC       the centrosome. Localizes to spindle microtubules in metaphase and
CC       anaphase and to the midbody during cytokinesis.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9HC98-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9HC98-2; Sequence=VSP_041798;
CC       Name=3;
CC         IsoId=Q9HC98-3; Sequence=VSP_041799;
CC       Name=4;
CC         IsoId=Q9HC98-4; Sequence=VSP_041800;
CC   -!- TISSUE SPECIFICITY: Ubiquitous, with highest expression in heart
CC       and skeletal muscle. Up-regulated in a variety of malignant
CC       cancers, such as breast, colon, lung, and gastric cancers.
CC       {ECO:0000269|PubMed:12054534, ECO:0000269|PubMed:20407017}.
CC   -!- INDUCTION: Up-regulated during the M phase of cell cycle
CC       progression. Down-regulated in both replicative and premature
CC       senescence of cancer cells. {ECO:0000269|PubMed:14563848,
CC       ECO:0000269|PubMed:21099361}.
CC   -!- DOMAIN: Displays an autoinhibited conformation: Tyr-108 side chain
CC       points into the active site, interacts with the activation loop,
CC       and blocks the alphaC helix. The autoinhibitory conformation is
CC       released upon binding with NEK9. {ECO:0000269|PubMed:19941817}.
CC   -!- PTM: Autophosphorylated. Phosphorylation at Ser-206 is required
CC       for its activation. Phosphorylated upon IR or UV-induced DNA
CC       damage. Phosphorylated by CHEK1 and CHEK2. Interaction with APBB1
CC       down-regulates phosphorylation at Thr-210.
CC       {ECO:0000269|PubMed:12840024, ECO:0000269|PubMed:17512906,
CC       ECO:0000269|PubMed:18728393, ECO:0000269|PubMed:20873783}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. NEK Ser/Thr
CC       protein kinase family. NIMA subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAG13417.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Sequence of unknown origin in the N-terminal part.; Evidence={ECO:0000305};
CC       Sequence=AAH00101.2; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAH04174.2; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAH04209.2; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAA85045.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF087909; AAG13417.1; ALT_SEQ; mRNA.
DR   EMBL; AB026289; BAA85045.1; ALT_INIT; mRNA.
DR   EMBL; AK294614; BAH11825.1; -; mRNA.
DR   EMBL; AK313071; BAG35899.1; -; mRNA.
DR   EMBL; AL162724; CAH70247.1; -; Genomic_DNA.
DR   EMBL; AL137846; CAH70247.1; JOINED; Genomic_DNA.
DR   EMBL; AL162724; CAH70254.1; -; Genomic_DNA.
DR   EMBL; AL137846; CAH70254.1; JOINED; Genomic_DNA.
DR   EMBL; AL137846; CAI10876.1; -; Genomic_DNA.
DR   EMBL; AL162724; CAI10876.1; JOINED; Genomic_DNA.
DR   EMBL; AL137846; CAI10883.1; -; Genomic_DNA.
DR   EMBL; AL162724; CAI10883.1; JOINED; Genomic_DNA.
DR   EMBL; CH471090; EAW87579.1; -; Genomic_DNA.
DR   EMBL; CH471090; EAW87581.1; -; Genomic_DNA.
DR   EMBL; BC000101; AAH00101.2; ALT_INIT; mRNA.
DR   EMBL; BC004174; AAH04174.2; ALT_INIT; mRNA.
DR   EMBL; BC004209; AAH04209.2; ALT_INIT; mRNA.
DR   EMBL; BC012761; AAH12761.1; -; mRNA.
DR   EMBL; CR457091; CAG33372.1; -; mRNA.
DR   EMBL; CR542222; CAG47018.1; -; mRNA.
DR   CCDS; CCDS48015.1; -. [Q9HC98-2]
DR   CCDS; CCDS55338.1; -. [Q9HC98-3]
DR   CCDS; CCDS55339.1; -. [Q9HC98-4]
DR   CCDS; CCDS6854.1; -. [Q9HC98-1]
DR   PIR; JC7838; JC7838.
DR   RefSeq; NP_001138473.1; NM_001145001.2. [Q9HC98-2]
DR   RefSeq; NP_001159639.1; NM_001166167.1. [Q9HC98-3]
DR   RefSeq; NP_001159640.1; NM_001166168.1. [Q9HC98-1]
DR   RefSeq; NP_001159641.1; NM_001166169.1. [Q9HC98-4]
DR   RefSeq; NP_001159642.1; NM_001166170.1. [Q9HC98-1]
DR   RefSeq; NP_001159643.1; NM_001166171.1. [Q9HC98-2]
DR   RefSeq; NP_055212.2; NM_014397.5. [Q9HC98-1]
DR   RefSeq; XP_005251721.1; XM_005251664.1. [Q9HC98-1]
DR   RefSeq; XP_006716999.1; XM_006716936.2. [Q9HC98-1]
DR   RefSeq; XP_016869706.1; XM_017014217.1. [Q9HC98-2]
DR   UniGene; Hs.197071; -.
DR   ProteinModelPortal; Q9HC98; -.
DR   SMR; Q9HC98; -.
DR   BioGrid; 116000; 65.
DR   IntAct; Q9HC98; 81.
DR   STRING; 9606.ENSP00000362702; -.
DR   BindingDB; Q9HC98; -.
DR   ChEMBL; CHEMBL4309; -.
DR   GuidetoPHARMACOLOGY; 2121; -.
DR   TCDB; 1.I.1.1.3; the nuclear pore complex (npc) family.
DR   iPTMnet; Q9HC98; -.
DR   PhosphoSitePlus; Q9HC98; -.
DR   BioMuta; NEK6; -.
DR   DMDM; 37537993; -.
DR   MaxQB; Q9HC98; -.
DR   PaxDb; Q9HC98; -.
DR   PeptideAtlas; Q9HC98; -.
DR   PRIDE; Q9HC98; -.
DR   DNASU; 10783; -.
DR   Ensembl; ENST00000320246; ENSP00000319734; ENSG00000119408. [Q9HC98-1]
DR   Ensembl; ENST00000373600; ENSP00000362702; ENSG00000119408. [Q9HC98-2]
DR   Ensembl; ENST00000373603; ENSP00000362705; ENSG00000119408. [Q9HC98-1]
DR   Ensembl; ENST00000394199; ENSP00000377749; ENSG00000119408. [Q9HC98-2]
DR   Ensembl; ENST00000539416; ENSP00000439651; ENSG00000119408. [Q9HC98-4]
DR   Ensembl; ENST00000540326; ENSP00000441469; ENSG00000119408. [Q9HC98-3]
DR   Ensembl; ENST00000545174; ENSP00000442636; ENSG00000119408. [Q9HC98-1]
DR   Ensembl; ENST00000546191; ENSP00000441426; ENSG00000119408. [Q9HC98-1]
DR   GeneID; 10783; -.
DR   KEGG; hsa:10783; -.
DR   UCSC; uc004bof.4; human. [Q9HC98-1]
DR   CTD; 10783; -.
DR   DisGeNET; 10783; -.
DR   GeneCards; NEK6; -.
DR   HGNC; HGNC:7749; NEK6.
DR   HPA; CAB045993; -.
DR   HPA; HPA056828; -.
DR   MIM; 604884; gene.
DR   neXtProt; NX_Q9HC98; -.
DR   OpenTargets; ENSG00000119408; -.
DR   PharmGKB; PA31550; -.
DR   eggNOG; KOG0591; Eukaryota.
DR   eggNOG; ENOG410XNQP; LUCA.
DR   GeneTree; ENSGT00760000118997; -.
DR   HOVERGEN; HBG105886; -.
DR   InParanoid; Q9HC98; -.
DR   KO; K20875; -.
DR   OMA; TLADFQI; -.
DR   OrthoDB; EOG091G0AER; -.
DR   PhylomeDB; Q9HC98; -.
DR   TreeFam; TF101021; -.
DR   Reactome; R-HSA-2980767; Activation of NIMA Kinases NEK9, NEK6, NEK7.
DR   Reactome; R-HSA-3301854; Nuclear Pore Complex (NPC) Disassembly.
DR   SignaLink; Q9HC98; -.
DR   SIGNOR; Q9HC98; -.
DR   ChiTaRS; NEK6; human.
DR   GeneWiki; NEK6; -.
DR   GenomeRNAi; 10783; -.
DR   PRO; PR:Q9HC98; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000119408; -.
DR   CleanEx; HS_NEK6; -.
DR   ExpressionAtlas; Q9HC98; baseline and differential.
DR   Genevisible; Q9HC98; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005874; C:microtubule; IEA:UniProtKB-KW.
DR   GO; GO:0005815; C:microtubule organizing center; IDA:HPA.
DR   GO; GO:0016607; C:nuclear speck; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0000922; C:spindle pole; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0019894; F:kinesin binding; IPI:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0004871; F:signal transducer activity; IMP:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0007059; P:chromosome segregation; IDA:UniProtKB.
DR   GO; GO:0000910; P:cytokinesis; TAS:UniProtKB.
DR   GO; GO:0031572; P:G2 DNA damage checkpoint; IMP:UniProtKB.
DR   GO; GO:0007067; P:mitotic nuclear division; IEA:UniProtKB-KW.
DR   GO; GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:2000772; P:regulation of cellular senescence; TAS:UniProtKB.
DR   GO; GO:0007346; P:regulation of mitotic cell cycle; TAS:UniProtKB.
DR   GO; GO:0030071; P:regulation of mitotic metaphase/anaphase transition; IDA:UniProtKB.
DR   GO; GO:0051225; P:spindle assembly; TAS:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Apoptosis; ATP-binding; Cell cycle;
KW   Cell division; Chromosome partition; Complete proteome; Cytoplasm;
KW   Cytoskeleton; Kinase; Magnesium; Metal-binding; Microtubule; Mitosis;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    313       Serine/threonine-protein kinase Nek6.
FT                                /FTId=PRO_0000086427.
FT   DOMAIN       45    310       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      51     59       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   REGION        1     44       Interaction with ARHGAP33, ANKRA2, CDC42,
FT                                PRDX3, RAD26L, RBBP6, RPS7 and TRIP4.
FT                                {ECO:0000269|PubMed:20873783}.
FT   REGION      267    270       Interaction with APBB1.
FT                                {ECO:0000269|PubMed:17512906}.
FT   ACT_SITE    172    172       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      74     74       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   SITE        108    108       Autoinhibitory.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000250|UniProtKB:Q8TDX7}.
FT   MOD_RES      37     37       Phosphoserine.
FT                                {ECO:0000269|PubMed:12840024}.
FT   MOD_RES     202    202       Phosphothreonine.
FT                                {ECO:0000269|PubMed:12840024}.
FT   MOD_RES     206    206       Phosphoserine; by NEK9.
FT                                {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:12840024,
FT                                ECO:0000269|PubMed:20873783}.
FT   MOD_RES     210    210       Phosphothreonine.
FT                                {ECO:0000269|PubMed:17512906}.
FT   VAR_SEQ       1      1       M -> MPRREVCWEAAHFRQEEQSLPRPRVRALVRLACRM
FT                                (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_041798.
FT   VAR_SEQ       1      1       M -> MGRRRPAPFRALVRLACRM (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_041799.
FT   VAR_SEQ       1      1       M -> MEATGWDSRCSPGTQVRALVRLACRM (in
FT                                isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_041800.
FT   MUTAGEN      74     74       K->M: Loss of autophosphorylation and of
FT                                kinase activity and induction of
FT                                apoptosis; when associated with M-75.
FT                                {ECO:0000269|PubMed:14563848,
FT                                ECO:0000269|PubMed:19001501}.
FT   MUTAGEN      75     75       K->M: Loss of autophosphorylation and of
FT                                kinase activity and induction of
FT                                apoptosis; when associated with M-74.
FT                                {ECO:0000269|PubMed:14563848,
FT                                ECO:0000269|PubMed:19001501}.
FT   MUTAGEN     108    108       Y->A: Increase in catalytic activity.
FT                                {ECO:0000269|PubMed:19941817}.
FT   CONFLICT     88     88       Q -> W (in Ref. 7; CAG33372).
FT                                {ECO:0000305}.
SQ   SEQUENCE   313 AA;  35714 MW;  B898DC57407A8C16 CRC64;
     MAGQPGHMPH GGSSNNLCHT LGPVHPPDPQ RHPNTLSFRC SLADFQIEKK IGRGQFSEVY
     KATCLLDRKT VALKKVQIFE MMDAKARQDC VKEIGLLKQL NHPNIIKYLD SFIEDNELNI
     VLELADAGDL SQMIKYFKKQ KRLIPERTVW KYFVQLCSAV EHMHSRRVMH RDIKPANVFI
     TATGVVKLGD LGLGRFFSSE TTAAHSLVGT PYYMSPERIH ENGYNFKSDI WSLGCLLYEM
     AALQSPFYGD KMNLFSLCQK IEQCDYPPLP GEHYSEKLRE LVSMCICPDP HQRPDIGYVH
     QVAKQMHIWM SST
//
